Opportunity

DIBBS #SPE2DP-26-T-4616

DLA Solicitation for Moxifloxacin Hydrochloride Tablets (9 Bottles, 400 mg)

Posted

August 12, 2026

Respond By

August 17, 2026

Identifier

SPE2DP-26-T-4616

NAICS

424210

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is soliciting offers for Moxifloxacin Hydrochloride Tablets. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Buyer: Nicholas Quigley - OEMs (Original Equipment Manufacturers): - TEVA Pharmaceuticals USA, Inc. - Rising Pharma Holdings, Inc. - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - National Stock Number (NSN): 6505-01-503-4772 - Quantity: 9 bottles - Approved part numbers: - TEVA: NDC00093-7387-56 - Rising Pharma: NDC57237-0156-30 - Notable Requirements: - Product must be FDA regulated - Packaging and labeling must comply with DLA Medical Marking Standard No. 1A - Delivery required within 20 days, FOB destination - Storage at controlled room temperature; avoid high humidity - Commercial packaging as specified in procurement documents

Description

MOXIFLOXACIN HYDROCHLO (QTY: 9, NSN: 6505-01-503-4772, Purchase Request: 7017829575) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing